These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 5672543)

  • 61. Replacement parts. How the FDA allows faulty, and sometimes dangerous, medical devices onto the market.
    Roane KR
    US News World Rep; 2002 Jul; 133(4):54-9. PubMed ID: 12152351
    [No Abstract]   [Full Text] [Related]  

  • 62. Amendment of various device regulations to reflect current American Society for Testing and Material citations. Food and Drug Administration, HHS. Direct final rule.
    Fed Regist; 2000 Jan; 65(15):3584-5. PubMed ID: 11010654
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The role of the Food and Drug Administration in instrumentation today and in the future.
    Yin L
    J Reprod Med; 1976 Apr; 16(4):184-6. PubMed ID: 1263181
    [No Abstract]   [Full Text] [Related]  

  • 64. Food and drug administration guidance sections. A new paradigm for medical devices. Committee for Clinical Review. FDA.
    Watson JT
    ASAIO J; 1994; 40(2):138-44. PubMed ID: 8003750
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Medical device listing: final rule.
    Fed Regist; 1978 Aug; 43(166):37990-8000. PubMed ID: 10238655
    [No Abstract]   [Full Text] [Related]  

  • 66. The medical device bill most likely to succeed.
    Radzius JR
    J Leg Med (N Y); 1975 May; 3(5):38-43. PubMed ID: 1079833
    [No Abstract]   [Full Text] [Related]  

  • 67. FDA issues final enforcement priorities for reprocessed medical devices.
    Hosp Outlook; 2000 Sep; 3(7):7, 12. PubMed ID: 11142987
    [No Abstract]   [Full Text] [Related]  

  • 68. Medical device regs: are they doing the job? FDA and industry share common goal of device safety.
    McDonnell EJ
    AORN J; 1981 Apr; 33(5):949-54. PubMed ID: 6908513
    [No Abstract]   [Full Text] [Related]  

  • 69. Guidance for the emergency use of unapproved medical devices; availability--FDA. Notice.
    Fed Regist; 1985 Oct; 50(204):42866-7. PubMed ID: 10274027
    [TBL] [Abstract][Full Text] [Related]  

  • 70. FDA releases Y2K list of critical medical devices.
    Hosp Peer Rev; 1999 Sep; 24(9):138, 143. PubMed ID: 10558180
    [No Abstract]   [Full Text] [Related]  

  • 71. Order for transitional class III devices; submission of safety and effectiveness information under section 520(1)(5)(A) of the Federal Food, Drug, and Cosmetic Act--FDA. Notice.
    Fed Regist; 1991 Nov; 56(220):57960-3. PubMed ID: 10115560
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Medical devices; medical device distributor reporting; opportunity for comments--FDA. Final rule; opportunity for comments.
    Fed Regist; 1993 Sep; 58(168):46514. PubMed ID: 10128334
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Medical devices; exemptions from premarket notification; class II devices--FDA, Final rule.
    Fed Regist; 1998 Nov; 63(212):59222-31. PubMed ID: 10187384
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Medical devices: the obvious, the readily-accepted, and the surprising.
    Tolomeo DE; Clarke LA
    J Health Life Sci Law; 2008 Jul; 1(4):117, 119-44. PubMed ID: 18717154
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Medical devices; gastroenterology and urology devices; classification of the electrogastrography system. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 1999 Sep; 64(184):51442-4. PubMed ID: 11010709
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Medical devices; exemptions from premarket notification; class II devices; vascular tunnelers. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Mar; 65(43):11466-7. PubMed ID: 11010650
    [TBL] [Abstract][Full Text] [Related]  

  • 77. "A passive lot ...".
    Dobelle WH
    Artif Organs; 1978 May; 2(2):206-7. PubMed ID: 687180
    [No Abstract]   [Full Text] [Related]  

  • 78. Medical devices. Part I. A primer on medical device regulation.
    Drew G
    FDA Consum; 1986 May; 20(4):24-7. PubMed ID: 10311540
    [No Abstract]   [Full Text] [Related]  

  • 79. Medical devices; 30-day notices and 135-day PMA supplement review--FDA. Direct final rule; withdrawal.
    Fed Regist; 1998 Aug; 63(154):42699. PubMed ID: 10182563
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Medical devices; preemption of state product liability claims--FDA. Withdrawal of proposed rule.
    Fed Regist; 1998 Jul; 63(142):39789-90. PubMed ID: 10181516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.